Virginia · 2026 Regular Session · Bill
HB 1025: Access to investigational drugs, etc.; patient with severely debilitating condition.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1025 is a bill introduced in the Virginia House on January 14, 2026. According to its official title, it concerns: Access to investigational drugs, etc.; patient with severely debilitating condition. Primary sponsor: Wendell Walker (Republican). It lists 1 additional sponsor. Most recent recorded action (February 18, 2026): Left in Committee Health and Human Services.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Wendell Walker | Primary sponsor | Republican | House | 52 |
| Wren Williams | Co-sponsor | Republican | House | 47 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Left in Committee Health and Human Services
- Subcommittee recommends laying on the table (7-Y 1-N)
- Fiscal Impact Statement from Department of Planning and Budget (HB1025)
- Assigned sub: Health
- Referred to Committee on Health and Human Services
- Prefiled and ordered printed; Offered 01-14-2026 26102452D